Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmermann, S.
Right arrow Articles by Martens, U. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmermann, S.
Right arrow Articles by Martens, U. M.

Stem Cells 2004;22:741-749 www.StemCells.com
© 2004 AlphaMed Press

Effects of Telomerase Modulation in Human Hematopoietic Progenitor Cells

Stefan Zimmermanna,b, Stefanie Glasera, Robin Kettelerc, Cornelius F. Wallera, Ursula Klingmüllerc, Uwe M. Martensa

a Freiburg University Medical Center, Department of Hematology/Oncology, Freiburg, Germany;
b Albert-Ludwigs-University, Department of Biology, Freiburg, Germany;
c Max-Planck Institute for Immunobiology, Hans-Spemann Laboratories, Freiburg, Germany

Key Words. Telomere length • Telomerase • Flow-FISH • Cord blood • Aging • Stem cells

Correspondence: Dr. Uwe Martens, Freiburg University Medical Center, Department of Hematology/Oncology, Hugstetterstr. 55, D-79106 Freiburg, Germany. Telephone: 49-761-270-3401; Fax: 49-761-270-3418; e-mail: martens{at}ukl.uni-freiburg.de

Loss of telomeric repeats has been causally linked to replicative senescence and aging in human cells. In contrast to normal somatic cells, which are telomerase-negative, hematopoietic stem cells have low levels of telomerase, which can be transiently upregulated upon cytokine stimulation. To examine whether ectopic expression of telomerase can overcome telomere erosion in hematopoietic progenitor cells, we overexpressed telomerase in CD34+ and AC133+ cord blood (CB) cells using retroviral vectors containing hTERT, the catalytic component of telomerase. Although the hTERT-transduced CB cells exhibited significantly elevated telomerase activity (approximately 10-fold), the mean telomere length was only increased up to 600 bp, which was in contrast to hTERT-transduced fibroblast cells gaining more than 2-kb telomeric repeats. Moreover, ectopic telomerase activity did not prevent overall telomere shortening, which was in the range of 1.3 kb in serum-free expansion culture. We also blocked endogenous telomerase activity by ectopic expression of dominant-negative hTERT. Whereas CB cells with absent telomerase activity showed reduced absolute numbers of colony-forming cells, we observed increased rates only for burst-forming units erythroid when the enzyme was overexpressed. These results suggest that telomere shortening in human hematopoietic progenitor cells cannot be compensated by increased levels of telomerase alone and is likely to be dependent on other factors, such as telomere binding proteins. Furthermore, telomerase function seems to be directly associated with the proliferative capacity of stem cells and may exert an additional role in lineage differentiation.




This article has been cited by other articles:


Home page
BloodHome page
O. Beyne-Rauzy, N. Prade-Houdellier, C. Demur, C. Recher, J. Ayel, G. Laurent, and V. Mansat-De Mas
Tumor necrosis factor-{alpha} inhibits hTERT gene expression in human myeloid normal and leukemic cells
Blood, November 1, 2005; 106(9): 3200 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Y. Wang, J. K. Warner, N. Erdmann, P. M. Lansdorp, L. Harrington, and J. E. Dick
Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells
PNAS, October 4, 2005; 102(40): 14398 - 14403.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. El-Daly, M. Kull, S. Zimmermann, M. Pantic, C. F. Waller, and U. M. Martens
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
Blood, February 15, 2005; 105(4): 1742 - 1749.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2004 by AlphaMed Press.